Robert A. Huddart

Institute Of Cancer Research And Royal Marsden Hospital FT
Sutton Upon Derwent, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 215 publications

Publisher Correction: HER2 in urothelial cancer: clinical speed outpacing diagnostic clarity.

Publisher Correction: HER2 in urothelial cancer: clinical speed outpacing diagnostic clarity.

Journal: Nature reviews. Urology

Published: May 27, 2026

HER2 in urothelial cancer: clinical speed outpacing diagnostic clarity.

HER2 in urothelial cancer: clinical speed outpacing diagnostic clarity.

Journal: Nature reviews. Urology

Published: May 05, 2026

Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study.

Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study.

Journal: British journal of cancer

Published: November 01, 2025

Cardiovascular disease risk among long-term testicular cancer survivors following contemporary cisplatin-based chemotherapy.

Cardiovascular disease risk among long-term testicular cancer survivors following contemporary cisplatin-based chemotherapy.

Journal: Journal of the National Cancer Institute

Published: October 07, 2025

Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study.

Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study.

Journal: EClinicalMedicine

Published: October 03, 2025

A standardised attenuated dosing of 177 lutetium-prostate-specific membrane antigen therapy for patients with metastatic castration-resistant prostate carcinoma and preexisting renal impairment.

A standardised attenuated dosing of 177 lutetium-prostate-specific membrane antigen therapy for patients with metastatic castration-resistant prostate carcinoma and preexisting renal impairment.

Journal: Nuclear medicine communications

Published: October 01, 2025

HER2 and urothelial carcinoma: current understanding and future directions.

HER2 and urothelial carcinoma: current understanding and future directions.

Journal: Nature reviews. Urology

Published: July 18, 2025

Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours.

Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours.

Journal: BJUI compass

Published: June 22, 2025

Evaluating participant experiences and tolerability with MR Linac imaging.

Evaluating participant experiences and tolerability with MR Linac imaging.

Journal: Technical innovations & patient support in radiation oncology

Published: June 10, 2025

Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer Survivors.

Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer Survivors.

Journal: Cancer medicine

Published: May 29, 2025

Management of Testicular Cancer.

Management of Testicular Cancer.

Journal: JCO oncology practice

Published: May 23, 2025

Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancer.

Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancer.

Journal: Frontiers in oncology

Published: April 23, 2025

Showing 1-12 of 215

Last Updated: 09/26/2026